Skip to main content
OpenTrials
Completed

NCT Number: NCT06698770

Leveraging Behavioral Science to Improve Medicine Optimization Conversations With Older Adults

Our online, survey-based experiment will include 2,400 adults who are 65-years and older (n=1,200 each from United States and Australia). Each participant will be asked to give their opinions on a hypothetical patient scenario that has been developed by our diverse team in partnership with our stakeholder organizations.This work is expected to significantly contribute to our understanding of how older adults make decisions about deprescribing medications.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Deprescribing

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Michigan

Ann Arbor, Michigan, 48109, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 65 years and older and resides in Australia or the United States

Treatment and study plan

Anticipated long-term use of medication

Other

In this hypothetical scenario, the doctor anticipates that the participant will take this medication for the rest of their life.

Period re-evaluation of medication

Other

In this hypothetical scenario, the doctor anticipates that the participant will take this medication for the rest of their life but will periodically re-evaluate the benefits and risks of the medication.

Primary outcomes

  1. Preference regarding starting medication

    Time frame: 1 year

    Response to statement, "Based on what you have read so far, what would you prefer to do with this diabetes medicine?" on a 6-point Likert scale with scale anchors 1=Strongly prefer not to start medicine and 6=Strongly prefer to start medicine

  2. Stopping medication

    Time frame: 1 year

    Response to statement, "Based on what you have read so far, what would you prefer to do with this diabetes medicine?" on a 6-point Likert scale with scale anchors 1=Strongly prefer not to continue and 6=Strongly prefer to stop

Sponsors and collaborators

Lead sponsor

University of Michigan

Other

Collaborators

  • University of Sydney

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Nov 21, 2024
Registry last updated
Sep 26, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.